BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26517945)

  • 1. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
    Pelagalli A; Nardelli A; Fontanella R; Zannetti A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
    Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
    Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model.
    Qin G; Chen Y; Li H; Xu S; Li Y; Sun J; Rao W; Chen C; Du M; He K; Ye Y
    Mol Med Rep; 2016 Jul; 14(1):57-68. PubMed ID: 27177128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic related functions of bone marrow mesenchymal stem cells are promoted by CBDL rat serum via the Akt/Nrf2 pathway.
    Shen CC; Chen B; Gu JT; Ning JL; Chen L; Zeng J; Yi B; Lu KZ
    Exp Cell Res; 2016 May; 344(1):86-94. PubMed ID: 27105936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair.
    Hu C; Yong X; Li C; Lü M; Liu D; Chen L; Hu J; Teng M; Zhang D; Fan Y; Liang G
    J Surg Res; 2013 Jul; 183(1):427-34. PubMed ID: 23462453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment.
    Han Y; Wu C; Wang J; Liu N
    Tumour Biol; 2017 May; 39(5):1010428317701631. PubMed ID: 28468584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
    Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
    Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion.
    Yu FX; Hu WJ; He B; Zheng YH; Zhang QY; Chen L
    World J Surg Oncol; 2015 Feb; 13():52. PubMed ID: 25890096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 16. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
    Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
    Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney.
    Liu N; Tian J; Cheng J; Zhang J
    J Cell Biochem; 2013 Dec; 114(12):2677-89. PubMed ID: 23794207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.
    Bertran E; Crosas-Molist E; Sancho P; Caja L; Lopez-Luque J; Navarro E; Egea G; Lastra R; Serrano T; Ramos E; Fabregat I
    Hepatology; 2013 Dec; 58(6):2032-44. PubMed ID: 23813475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway.
    Xiu G; Li X; Yin Y; Li J; Li B; Chen X; Liu P; Sun J; Ling B
    Cell Transplant; 2020; 29():963689720929992. PubMed ID: 32452221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.